Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab: a comparative overview

Syed, Faisal; Muhammad, Tahir; Alyscia, Cheema; Muhammad, Anjum

Syed, Faisal; Muhammad, Tahir; Alyscia, Cheema; Muhammad, Anjum.

Pakistan Journal of Medical Sciences. 2018; 34 (1): 221-225

in English | IMEMR | ID: emr-192402

ABSTRACT

ABSTRACT

Objective:

To compare the success in patients having vitreous hemorrhage undergoing pars plana vitrectomy with or without preoperative intravitreal injection of Bevacizumab

Subject(s)

Humans; Male; Female; Middle Aged; Vitrectomy; Bevacizumab/administration & dosage; Bevacizumab/therapeutic use; Diabetic Retinopathy; Diabetes Complications; Eye Diseases; Intravitreal Injections

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Main subject: Vitrectomy / Diabetes Complications / Diabetic Retinopathy / Eye Diseases / Intravitreal Injections / Bevacizumab Type of study: Controlled clinical trial Limits: Female / Humans / Male Language: English Journal: Pak. J. Med. Sci. Year: 2018

Similar

MEDLINE

LILACS

LIS

Search on Google

XML